🔎 Trials Near Me

Hjem › Astma › Missouri

Astma kliniske forsøg i Missouri

11 studier for Astma søger deltagere på steder i Missouri.

Byer i Missouri

Officiel studietekst (engelsk)

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  • GSK Investigational Site, Columbia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07645248

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, St Louis
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT07301255

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. sep. 2026 · NCT06977581

Resources and Education for Addressing Chronic Health (REACH)

  • WashU School of Medicine, St Louis
Rekrutterer
Alder 3 til 18 · Alle køn · Opdateret 21. sep. 2026 · NCT07819747

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

  • Affinia healthcare, 2220 Lemp Ave, St Louis
  • Affinia healthcare, 1717 Biddle Street, St Louis
  • Affinia healthcare, 4414 North Florissant Avenue, St Louis
  • og 4 flere
RekruttererFase 4
Alder 12 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07241117

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12149, Columbia
  • Teva Investigational Site 12108, St Louis
  • Teva Investigational Site 12089, St Louis
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT06664619

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Kansas City
  • Research Site, St Louis
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 13. aug. 2026 · NCT06307665

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

  • Research site, Kansas City
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07532265

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

  • GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT06979323

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • University of Missouri, Columbia
RekruttererFase 4
Alder 13 til 75 · Alle køn · Opdateret 29. okt. 2025 · NCT07052942

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.